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Abstract 
BACKGROUND: Interleukin-10 is a cytokine that has a pleiotropic effect on the immune system and 
inflammation. IL-10 can contribute to the anti-tumour immune response by increasing HLA-G expression. 
AIM: This study aimed to determine the effect of IL-10 induction on membrane HLA-G expression and soluble 
HLA-G production of HeLa CCL-2 cells. 
METHODS: HeLa CCL-2 cells were cultured in the well plate and divided into 4 groups consist of 1 control group 
that was not induced by IL-10 and 3 treatment groups that were induced by IL-10 500 ng/ml, 1000 ng/ml and 2000 
ng/ml respectively. All groups were incubated for 48 hours in a 37°C incubator at 5% CO2 atmospheric pressure. 
HLA-G measurements were carried out both in cell lysate and cell culture supernatant using ELISA and in 
membrane-bound using immunofluorescence method. The expression of HLA-G in membrane-bound calculated 
using the ImageJ application. Data obtained were analysed by ANOVA and LSD test. 
RESULTS: In the control group, the HLA-G level in the culture supernatant was higher than in cell lysate (p = 
0.000), as well as in all treatment groups (p = 0.000). There were significant differences between the treatment 
group (p = 0.000) and within the treatment group (p = 0.000) at HLA levels. The highest expression of HLA-G in 
HeLa cell membranes found in cell culture induced by IL-10 concentrations of 500 ng/ml, i.e., 59.28 AU in 
view. HLA-G membrane expression in the IL-10 1000 ng/ml induced group was significantly different from all 
treatment groups (p = 0.000). 
CONCLUSION: HeLa CCL-2 cells express HLA-G on the membrane and release dissolved HLA-G without 
induction of IL-10 although IL-10 induction augments the presence and the production of HLA-G in HeLa CCl-2 
cells. 
 
 
 
 
 
 
Introduction 
 
Interleukin-10, also called human cytokine 
synthesis inhibitory factor, is a cytokine secreted by 
monocytes which has a pleiotropic effect on the 
immune system and inflammation. Most leukocytes 
secrete IL-10 to a certain level. The highest secretion 
of IL-10 comes from monocytes and their mature 
forms: macrophages and dendritic cells. Specific 
granulocytes and agranulocytes: eosinophil and NK 
cells, and small lymphocytes: T and B cells, also 
release IL-10 but at lower levels [1]. 
Human leukocyte antigen (HLA)-G is HLA 
class 1 molecule consists of membrane-bound 
isoform (mHLA-G) namely HLA-G1, HLA-G2, HLA-G3 
and HLA-G4 and 3 soluble HLA-G (sHLA-G) namely 
HLAG5, HLA-G6 and HLA-G7 [2]. HLA-G expression 
is initially observed in extra-villous cytotrophoblasts 
and is considered to play an important role in fetal-
maternal immune tolerance [3]. In addition to 
extravillous cytotrophoblasts, HLA-G expression is 
limited to some healthy adult tissues, including the 
cornea, thymus medulla and Langerhans Island of 
pancreatic [4]. HLA-G expression can be activated in 
a variety of pathological conditions such as cancer, 
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viral infections, organ transplants, autoimmune 
diseases, and inflammation [5]. HLA-G has the effect 
of inhibiting the immune response and induces the 
production of regulator and suppressor cells so that 
tumour cells can escape immune surveillance [6]. 
It has been reported that IL-10 can contribute 
to anti-tumour immune responses by either 
decreasing regulation of HLA class I expression 
allowing tumours to exit lysis mediated by CTLs or by 
increasing HLA-G expression allowing cells to escape 
lysis by NK cells through interaction with inhibiting 
killer receptors in NK cells. In cervical cancer, HLA-G 
and IL-10 expression can be higher in tumour cells 
than in normal cervix and may be involved in early 
carcinogenesis. However, the relationship between 
IL10 and HLA-G in cervical cancer is not yet cleared 
[7]. 
Polakova & Russ, in 2000, informs that HeLa 
cells do not express HLA-G antigens by observing 
flowcytometry using 87G and 01G antibodies [8]. 
Flajollet et al., in 2009 using ras-responsive element-
binding protein 1 (RREB-1) as an HLA-G transcription 
suppressor that has been known to suppress HLA-G 
promoters in HLA-G negative cells (HeLa cells) 
revealed that HeLa cells were referred to as negative 
cells HLA-G [9]. Therefore, in this study, we want to 
study the ability of IL-10 to induce HLA-G expression 
using the HeLa CCL-2 cells line. 
 
 
Material and Methods 
 
Chemicals and reagents 
The research materials were HeLa CCL-2 
cervical cancer cell line (ATCC), recombinant IL-10 
(Elabscience), Alpha MEM (Gibco), 2% Penicillin 
Streptomycin, Fungison (Amphotericin B 0.5%), Fetal 
bovine serum (ATCC) 12.5% and Horse serum 
(ATCC) 12.5%, recombinant HLA-G (4H84) (Santa 
Cruze), and HLA-G Elisa kit (Elabscience). 
The tools used laminar airflow Hood/tissue 
culture cabinet (Nuaire), CO2 incubator, inverted 
microscope, centrifuge, 24-well plate, 96 well plates, 
micropipette, micro-tip, spectrophotometry, ELISA 
reader, Improved Neubauer Hemocytometer 
Chamber, fluorescent microscope (Olympus), round 
coverslip, object-glass, flask 25. 
 
Human cell line culture 
The HeLa CCL-2 cell lines were grown in 
Alpha MEM supplemented with Glutamax- I,4500 
mg/L glucose (Invitrogen), 10% FCS (BioWhittaker), 
1000 U of Penicillin, and 10 μg/ml Streptomycin. The 
cells were cultured in flask 25 and maintained at 37°C 
and 5% CO2 until confluent. Trypsinization, the 
number of cells per ml, was counted with a 
hemocytometer. 
 
HeLa CCL-2 Cell Induction with IL-10 
A total of 105 cells/ml was seeded into the 24 
wells plate, in which coverslips had been placed. IL-10 
with several concentrations of 500 ng/ml, 1000 ng/ml, 
and 2000 ng/ml was added in HeLa cell culture in 
triplicate. For analysis of HLA-G secretion in the 
supernatant and cell lysate, 4 x 104 HeLa cells were 
also cultured into the 96 wells plate and were induced 
with IL-10. All plates were incubated for 48 hours in a 
37°C incubator with CO2 pressure 5 atmospheres. 
 
Measurement of HLA-G membrane-bound 
 expression with Double-label 
 immunofluorescence 
Cells on the coverslip were fixed for 10 min in 
absolute methanol at 4°C. Samples were then 
rehydrated in PBS tween 0.05% 3 times, and 
subsequently PBS Triton-X 1000 0.1% for 5 min. Cells 
were incubated for 60 min in blocking buffer (1%: BSA 
0.1 g in PBS 10 ml). The HLA-G (4H84) mAbs 1:400 
were applied and then incubated and were followed 
by incubations with biotinylated goat anti-mouse mAb 
and FITC-labeled streptavidin (1:1000) in the dark. 
After washing, goat anti-mouse labelled antibody was 
added for 60 min, followed by DAPI (1:1000) as 
counterstain. Samples were then mounted on object 
glass and observed by a fluorescence microscope. 
 
Measurement of HLA-G supernatant and 
 Celllysate with Elisa 
Cell culture supernatant: The samples were 
centrifuged for 20 min at 1000 × g at 2 ~ 8°C and the 
supernatant were collected. 
Cell lysates: The cells were washed gently 
with a moderate amount of pre-cooled PBS and 
dissociated the cells using trypsin. The cell 
suspension was collected into a centrifuge tube and 
centrifuged for 5 min at 1000 × g. The medium was 
discarded and washed 3 times with pre-cooled PBS. 
For each 1 × 10
6
 cells, added 150-250 μL of pre-
cooled PBS to keep the cells suspended. The freeze-
thaw process was repeated several times until the 
cells are fully lysed and centrifuged for 10 min at 1500 
× g at 4°C. The cell fragments were removed; the 
supernatant was collected to carry out the assay. 
 
Elisa (HLA-G Elisa kit: Elabscience) 
The standard working solution added to the 
first two columns: Each concentration of the solution is 
added in duplicate, to one well each, side by side (100 
μL for each well). The samples were added to the 
other wells (100 μL for each well). The plate covered 
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with the sealer provided in the kit and incubated for 90 
min at 37°C. The liquid was removed out of each well, 
do not wash. Immediately 100 μL of Biotinylated 
Detection Ab working solution added to each well. 
Cover with the Plate sealer and gently mix up and 
incubated for 1 hour at 37°C.  
The solution was aspirate from each well, and 
350 μL of wash buffer was added to each well. Soak 
for 1 ~ 2 min and the solution was aspirated from each 
well and pat it dry against clean absorbent paper. 
Repeat this wash step 3 times. 100 μL of HRP 
Conjugate working solution was added to each well 
was covered with the Plate sealer and incubated for 
30 min at 37°C. The solution was aspirate from each 
well, repeat the wash process for five times. 90 μL of 
Substrate Reagent was added to each well. Cover 
with a new plate sealer. Incubate for about 15 min at 
37°C. The plate was protected from light. 50 μL of 
Stop Solution was added to each well. The optical 
density (OD value) of each well was determined at 
once with a micro-plate reader set to 450 nm. 
 
Statistical analysis 
From the data obtained, a normality test was 
carried out using the Kolmogorov-Smirnov test. The 
data obtained will be tested by ANOVA (p < 0.05), and 
differences between groups were further tested by 
Least Significant Difference (LSD). 
 
 
Results 
 
In this study, HeLa CCL-2 cell cultures were 
divided into a control group and treatment groups. In 
the control group, it was found that supernatant HLA- 
G level was higher than HLA-G cell lysate level (65.50 
ng/ml vs 21.59 ng/ml), as well as in all treatment 
groups as shown in Table 1. The mean HLA-G level in 
the supernatant (77.372 ng/ml) was higher than the 
mean HLA-G level in cell lysate (28.68 ng/ml). 
Table 1: Comparison of HLA-G Supernatants with HLA-G 
CellLysate Level after IL-10 Induction 
Sample N Mean of HLA-G (ng/ml) 
Supernatants Control 
 IL-10 500 ng/ml 
 IL-10 1000 ng/ml 
 IL-10 2000 ng/ml  
3 
3 
3 
3 
65.50 
76.66 
83.10 
84.24 
CellLysate Control 
 IL-10 500 ng/ml 
 IL-10 1000 ng/ml 
 IL-10 2000 ng/ml 
3 
3 
3 
3 
21.59 
24.32 
32.67 
36.16 
 
There was a significant difference among 
treatment groups and within the treatment group on 
the levels of HLA-G secreted in the supernatant or on 
cell lysate (p = 0.000; p = 0.000). Comparison of HLA-
G supernatant and cell lysate levels, as illustrated in 
Figure 1. 
 
Figure 1: Comparison of HLA-G Supernatant Levels and Cell 
Lysate CCL-2 HeLa Cells After IL-10 Induction; The highest HLA-G 
secretion in the supernatant and cell lysate of HeLa cell culture 
were shown after induction of IL-10 concentration of 2000 ng/ml 
(84.24 ng/ml and (36.16 ng/ml)); Comparison the HLA-G 
supernatant and cell lysate on CCL-2 HeLa Cells culture differed 
significantly between control and treatment groups (sig < 0.05) 
 
Membrane-bound HLA-G expression of HeLa 
CCL-2 cells was observed using a fluorescent 
microscope. Illustrations of HLA-G expression that 
were obtained in each treatment group is shown in 
Figure 2. 
 
Figure 2: HLA-G Expression in HeLa CCL-2 Cells 
Culture; Fluorescent images in the treatment group induced by IL-
10 500 ng/ml gives a stronger expression of HLA-G than the other 
treatment groups. By using ImageJ application, the mean HLA-G 
expression for the control and treatment fields were: 37.26; 59.28; 
57.16 and 47.11 AU which were observed under a fluorescent 
microscope with a 400-x magnification 
 
The averages of HLA-G expression were 
analysed using the ImageJ application (table 2). The 
highest expression of HLA-G (59.28 AU) was found 
on HeLa cell membranes IL-10 500 ng/ml-induced 
group. After being analysed with ANOVA, HLA-G 
membrane expression in the non-IL-10-induced group 
was significantly lower from the IL-10 induced groups, 
that were 500 ng/ml (p = 0.014) and 1000 ng/ml (p = 
0.020). HLA-G membrane expression in the IL-10 500 
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ng/ml-induced group not significantly different from the 
IL-10-induced group 1000 ng/ml (p = 0.708) and 2000 
ng/ml (p = 0.083). HLA-G membrane expression in the 
IL-10 1000 ng/ml-induced group not significantly 
different from the IL-10-induced group 2000 ng/ml (p = 
0.130). Hence, HLA-G membrane expression in the 
IL-10 500 ng/ml and 1000 ng/ml-induced group was 
significantly different from non-IL-10 inducing, as 
shown in Figure 3 and Table 2. 
Table 2: HLA-G Expression of CCL-2 HeLa Cell Membrane after 
IL-10 Induction 
Treatment Group N Mean of HLA-G expression in view (AU) 
Control 5 37.259 
IL-10 500 ng/ml  5 59.279 
IL-10 1000 ng/ml 5 57.156 
IL-10 2000 ng/ml 5 47.108 
 
 In the control group, HeLa cells can express 
HLA-G on the membrane, although this group did not 
receive IL-10. HLA-G expression in the group treated 
with IL-10 500 ng/ml had the highest expression 
(59.279 AU), and significantly different from the 
control (p = 0.014). 
 
Figure 3: Comparison of HLA-G Expression of HeLa CCL-2 Cell 
Membrane 
 
 
Discussion 
 
Parameters of the tumour microenvironment 
that play a role in modulation of the HLA-G gene 
include stress conditions such as heat shock and 
hypoxia; cytokines such as IFNƔ, IL-10, leukaemia 
inhibitory factor (LIF), and GM-GSF; and hormones 
such as glucocorticoids and progesterone. The 
mechanism of action of all these parameters is not yet 
clear. In this study, IL-10 was used to induce the 
production of HLA-G protein on HeLa CCL 2 cells as a 
model of tumour cells. The results of this study 
demonstrated that the HeLa CCL-2 cells could 
express and secrete HLA-G with or without IL-10 
treatment. The higher the concentration of IL-10 
treatment, the higher the HLA-G expression in the 
membrane and HLA-G secretion to the supernatant, 
as shown in Table 1 and Figure 1. The previous study 
by Polakova & Russ, in 2000, Hela cells, along with 
61 other cells line did not express HLA-G antigens as 
observed by flow cytometry using 87G and 01G 
antibodies. Research several years later, using the 
RT- PCR method revealed that stable levels of HLA-G 
mRNA in HeLa cells were very low(~1.5 x 10-5) 
compared to HLA-G levels in positive. JEG-3 
choriocarcinoma cells with HLA-G (HLA-G mRNA 
level: 1). RREB-1 and DNA methylation at the HLA-G 
locus is complementary mechanisms [9]. However, 
this study proved that HeLa cells could express HLA-
G before or after IL-10 induction. 
The previous study of trophoblastic cells, IL-
10 can activate HLA-G transcription in trophoblastic 
tissue. Northern blotting analysis and quantification of 
total RNA from trophoblasts showed that IL-10 
induction increased the transcription level of HLA-G 
mRNA at least 7 times compared to the HLA- G 
mRNA of cells without IL-10. The RNase protection 
test also showed that HLA-G mRNA levels were 
stabilised 7.2-fold after induction of IL-10 in 
trophoblastic explants. To analyse IL-10-induced HLA- 
G transcription patterns, HLA-G-specific primers are 
used to strengthen the isolated HLA-G mRNA form. 
Southern blotting of HLA-G RT-PCR products reveals 
that induction of IL-10 enhances all transcripts, 
including G5 and G6, which encode dissolved HLA-G 
isoforms [11]. 
In this study, IL-10 treatment induces HLA-G 
expression on the HeLa cell membrane as well as 
HLA-G secretion into the HeLa cells culture 
supernatant. Possible underlying mechanisms can be 
explained based on previous studies on cervical 
cancer. It is well-known that progression is associated 
with a shift from Th1 to Th2 cytokine production. This 
shift toward a Th2 cytokine profile, characterised by 
IL-10 secretion, is associated with the progression of 
premalignant lesions to cancer [13]. Moreover, 
another study showed peripheral blood monocytes 
expressed classic HLA class I and proteins containing 
IL-10 receptors. HLA-G transcripts are analysed by 
RT- PCR, using primary HLA-G and HLA-G5-specific 
primers, which encode HLA-G5 soluble proteins. 
Moderate HLA-G gene transcripts in monocytes, weak 
HLA-G transcription signals enhanced after induction 
of IL-10. It is possible that IL-10 may contribute to the 
activation of HLA-G expression in melanoma cells, 
thus participating in the escape of tumours from 
immunosurveillance [11]. HLA-G expression at the 
surface of tumour cells can participate in the 
evaluation of anti-tumour immune responses and 
favour tumour progression [12]. 
In this study, the results of HLA-G production 
of cell lysate and HLA-G secretion in HeLa cell culture 
supernatant were confirmed by microscopic 
examination with HLA-G antibody (4H84) using a 
fluorescent microscope to determine the quantity of 
membrane HLA-G expression in each group 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
3558                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
treatment. From the results of microscopic 
observations of the field of view, the highest results 
were obtained in the treatment group with IL-10 500 
ng/ml induction with a mean of 59,28 AU, which was 
directly proportional to HLA-G levels in the 
supernatant and cell lysate. HLA-G expression of the 
membrane increases after IL-10 500 ng/ml treatment 
and decreases again at IL-10 2000 ng/ml. These 
results were consistent with previous studies which 
that analysed the expression of HLA-G proteins in 
induced and non-IL-10-induced monocytes using anti- 
HLA-G-specific 87G mAb. The study showed that the 
percentage of cells with positive HLA-G and HLA-G 
cell surface density increased after IL-10- induction 
[11]. 
In conclusion, HeLa CCL-2 cells expressed 
HLA-G on its membrane and release dissolved HLA-G 
without induction of IL-10, although IL-10 induction 
augments the presence and the production of HLA-G 
in HeLa CCl-2 cells. 
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